Project Grant HT94252310520
Award Date
7/1/23
Completion Date
6/30/26
Dollars Obligated
$513K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
The Ohio State University received a $248,237 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund a 3-year project from July 1, 2023 to June 30, 2026 to research and address traumatic brain injuries among law enforcement officers. No additional details about specific products or services to be delivered under this award were provided. The Military Medical Research and Development program supports basic,...
This federal Project Grant award for $7,700,740.00 was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Ohio State University. The funding supports a 4-year research project titled "CONSEQUENCES OF BRAIN INJURY ON GLIA-NEURON DYNAMICS, NEUROPATHOLOGY, AND NEUROPSYCHIATRIC ILLNESS" aimed at investigating the effects of brain injury on glial-neuronal interactions, neuropathology, and neuropsychiatric conditions. The...
This federal Project Grant award of $267,311 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a randomized clinical trial utilizing crisis response planning for suicide prevention in military personnel with traumatic brain injury. The award was made to The Ohio State University, which will serve as the prime recipient, with a performance period from August 1, 2024 to July 31, 2027. The project aims to...
This Project Grant award of $717,896.00 was provided by the Defense Health Agency to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420). The purpose of the award is to conduct research on prebiotic and probiotic interventions for the treatment of traumatic brain injury (TBI)-induced microbiome dysfunction. The Ohio State University is the prime awardee, and they have issued a $XXX,XXX subaward to the Research Institute at Nationwide Children's...
The Department of Defense's Defense Health Agency awarded a $1,158,179.00 Project Grant to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420) to deliver a sustained therapeutic protein cocktail delivery system to prevent vision loss after ocular trauma. The project aims to develop innovative treatments for military service members and veterans by conducting basic, translational, and clinical research. As a sub-award under this grant, the...
The Department of the Army Medical Command awarded a $2,289,304.00 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Medical College of Wisconsin, Inc. The grant, with a performance period from August 1, 2024 to July 31, 2027, is funding research to improve in-hospital and post-discharge patient education for mild traumatic brain injury. The grant includes a sub-award to The Ohio State University to support this research initiative....
This $249,960 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Ohio State University to investigate the effects of the aged inflammatory central nervous system (CNS) microenvironment on oligodendroglial properties and remyelination capacity. The research aims to advance scientific understanding of age-related changes in the CNS that can impact myelin repair, with potential applications for...
This $377,227 Project Grant was awarded on August 15, 2024 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The prime awardee, Florida State University, will conduct research related to traumatic brain injury and psychological health. The funded project aims to develop innovative...
The Ohio State University will receive $1,181,604 under a four-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The funding will support research into developing new methods to access extracellular vesicle MDM2 DNA cargo as a potential biomarker for liposarcoma. The grant aims to transform health care for service members and the public through innovative biomedical research investigating medical solutions for...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,181,250.00 to The Ohio State University to conduct research on the use of MIF inhibition and glucocorticoid therapeutics as a synergistic treatment to promote neuronal survival in traumatic retinal injury. The research aims to develop novel therapies for this type of injury, which is of particular relevance to military personnel. The...